Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3993967018 | Tazemetostat hydrobromide | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3993968011 | Tazemetostat hydrobromide (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Tazemetostat hydrobromide | Is a | Enzyme inhibitor | false | Inferred relationship | Some | ||
| Tazemetostat hydrobromide | Is a | Methyltransferase inhibitor | true | Inferred relationship | Some | ||
| Tazemetostat hydrobromide | Is modification of (attribute) | Tazemetostat (substance) | true | Inferred relationship | Some | ||
| Tazemetostat hydrobromide | Has disposition (attribute) | Methyltransferase inhibitor (disposition) | true | Inferred relationship | Some | ||
| Tazemetostat hydrobromide | Is a | Antineoplastic agent (substance) | true | Inferred relationship | Some | ||
| Tazemetostat hydrobromide | Is a | Substance with benzamide structure | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Tazemetostat (as tazemetostat hydrobromide) 200 mg oral tablet | Has precise active ingredient | True | Tazemetostat hydrobromide | Inferred relationship | Some | 1 |
This concept is not in any reference sets
FHIR